LinkedIn · Jul 2026
Founder Angelica Iacovelli publicly announced the award win and framed it as recognition for Nucleo's CT/MRI imaging work.
Company research
Public company, workplace, funding, and market signals
Overview
Nucleo is a YC F25 medtech startup building an AI platform for oncology CT analysis that automates extraction of body composition, sarcopenia, lesion sizing, and RECIST-based classification to speed cancer diagnosis and treatment workflows.
Primary product
AI-powered oncology CT scan analysis platform
Founded
2025
Headquarters
San Francisco, California, United States
Team size
1-10
Industry
Technology, Information and Internet
Sub-industry
Automated cancer diagnostics / medical imaging AI
Business model
B2B
Open Positions
0 jobs at Nucleo
No open positions
Check back later for new openings